GENEMEDICS APP

GENEMEDICS NUTRITION

Ginsenoside Rg3

Author: Dr. George Shanlikian, M.D.  |   Last Updated: February 1st, 2024

Share This Page

Book a Free Consultation

Potential Benefits of Ginsenoside Rg3

Ginsenoside Rg3 is a potent compound known for its diverse health benefits, including improving memory, reducing heart disease risk, regulating blood pressure, enhancing immune function, aiding in weight loss, accelerating wound healing, preventing cancer, elevating mood, and stabilizing blood sugar levels. Its multifaceted effects have been supported by numerous studies, making it a valuable component in holistic health approaches. With such a range of advantages, the ginsenoside Rg3 benefits are increasingly recognized and sought after in the world of natural remedies.

  • Improves memory and prevents brain disorders [1-18]
  • Lowers the risk of heart disease [19-31]
  • Lowers blood pressure [26, 32-33]
  • Boosts immune function [34-39]
  • Helps lose weight [40-42]
  • Accelerates wound healing [43-49]
  • Prevents cancer [50-79]
  • Improves mood [18, 80-81]
  • Improves blood sugar levels and treats diabetic symptoms [82-95]

Key Takeaways of Ginsenoside Rg3

  • Ginsenoside Rg3, derived from Panax ginseng, possesses a myriad of health benefits, including improved memory, cardiovascular protection, immune function enhancement, and potential cancer prevention.
  • Ginsenoside Rg3 works through a multifaceted approach, including anti-cancer mechanisms, neuroprotective effects, cardioprotective roles, and metabolic regulation, among others.
  • Ginsenoside Rg3 stands out for its neuroprotective properties against oxidative stress and inflammation, as well as its cardioprotective role in reducing oxidative stress and arterial plaque formation.
  • While ginsenoside Rg3 has been associated with some side effects, they are very uncommon, and there’s a possibility that they might not be directly related to the use of the compound.
  • Ginsenoside Rg3 not only neutralizes free radicals due to its antioxidant properties but also modulates the production of pro-inflammatory cytokines, supporting overall cellular health and reducing inflammation.

What is Ginsenoside Rg3?

Ginsenoside Rg3 is a natural product derived from Panax ginseng, particularly abundant in red ginseng. It is one of the active compounds found in certain species of the ginseng plant. As more people recognize its health benefits, there is a rising interest in the ginsenoside Rg3 supplement in the market. Ginsenoside Rg3 plays an essential role in nerve cell and cardiovascular protection. Additionally, it is known for its potent anti-cancer effects and brain-boosting properties.

The mechanisms by which ginsenoside Rg3 exerts its therapeutic effects are multifaceted, encompassing anti-cancer, neuroprotective, cardioprotective, immune-modulating, metabolic-regulating, antioxidant, and anti-inflammatory actions, among others. Given its wide array of benefits, many individuals are considering the addition of a ginsenoside Rg3 supplement to their daily regimen. This compound has garnered attention in the medical and scientific communities due to its diverse range of potential health benefits.

How Ginsenoside Rg3 Works

Ginsenoside Rg3 is one of the active compounds found in certain species of the ginseng plant. The mechanisms by which ginsenoside Rg3 exerts its therapeutic effects are multifaceted and are still the subject of ongoing research. Here are some insights into how ginsenoside Rg3 works:

  • Anti-cancer Mechanism: Ginsenoside Rg3 has been shown to inhibit tumor growth and metastasis, demonstrating the anticancer effects of ginsenoside. One of the mechanisms through which it acts is that ginsenoside Rg3 induces apoptosis (programmed cell death) in cancer cells. This apoptosis-inducing property is crucial for its anti-cancer effects. Furthermore, besides the fact that ginsenoside Rg3 induces apoptosis, it also inhibits tumor angiogenesis (formation of new blood vessels that feed the tumor), emphasizing once again the anticancer effects of ginsenoside. Additionally, it suppresses the invasive and migratory capabilities of cancer cells.
  • Neuroprotective Effects: Ginsenoside Rg3 can protect nerve cells against oxidative stress induced by various external and internal factors. Additionally, it guards against inflammation, potentially aiding in memory enhancement and the prevention of brain disorders.
  • Cardioprotective Role: It may protect the heart and blood vessels by reducing oxidative stress, and inflammation, and preventing the formation of plaques in arteries.
  • Immune Modulation: Ginsenoside Rg3 can enhance the activity of certain immune cells, thereby boosting the body’s defense mechanisms. Through its unique properties, ginsenoside Rg3 enhances the body’s natural ability to ward off potential threats. Additionally, studies suggest that ginsenoside Rg3 enhances the overall immune response, further fortifying the body against foreign invaders.
  • Metabolic Regulation: Ginsenoside Rg3 has been shown to have a role in regulating blood sugar levels, making it potentially beneficial for diabetic patients. It might improve insulin sensitivity and reduce insulin resistance.
  • Antioxidant Action: Like many ginsenosides, Rg3 possesses antioxidant properties, which means it can neutralize free radicals in the body, reducing oxidative stress and potential damage to cells.
  • Anti-inflammatory Effects: Ginsenoside Rg3 can modulate the production of pro-inflammatory cytokines and thereby reduce inflammation in the body.
  • Wound Healing: It may promote wound healing by accelerating the proliferation and migration of skin cells, as well as promoting angiogenesis in wound sites.

Ginsenoside-Rg3

Chemical Structure of Ginsenoside Rg3

Research on Ginsenoside Rg3

A. Improves Memory and Prevents Brain Disorders

Man with glasses deep in thought, symbolizing enhanced cognitive function and memory.

A convincing number of studies suggest that ginsenoside Rg3 can improve memory and prevent brain disorders through its neuroprotective effects:

  1. In mice, oral administration of ginsenoside Rg3 for 4 days significantly reversed memory impairment induced by ethanol. [1]
  2. In cultured rat brain cells, ginsenoside Rg3 protected against glutamate-induced neurodegeneration. [2]
  3. A cell study reported that pretreatment of brain cells with ginsenoside Rg3 resulted in an increased survival rate via its antioxidant and anti-inflammatory properties. [3]
  4. In an animal model of brain inflammation, ginsenoside Rg3 supplementation at 20 and 30 mg/kg oral doses significantly reduced inflammation by reducing the levels of inflammatory substances such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and IL-6 mRNA. [4]
  5. In rats with cognitive impairment, ginsenoside Rg3 treatment restored learning and memory functions. [5]
  6. A cell study also reported that ginsenoside Rg3 prevented brain inflammation by reducing inflammatory stimuli in the majority of brain tissues. [6]
  7. A study conducted on animal models of Alzheimer’s disease found that ginsenoside Rg3 can help prevent or slow the development of neurological disorders due to its anti-inflammatory activity in the brain. [7]
  8. A cell study found that ginsenoside Rg3 can help prevent Alzheimer’s disease by reducing the levels of abnormal protein structures in the brain. [8]
  9. In a rat model of Alzheimer’s disease, ginsenoside Rg3 prevented cognitive impairment by improving mitochondrial dysfunction. [9-11]
  10. In mice and rats, ginsenoside Rg3 ameliorated scopolamine-induced learning deficits through the inhibition of acetylcholinesterase activity and NF-κB signaling in the brain. [12-13]
  11. Studies reported that ginsenoside Rg3 exerts its neuroprotective effects by suppressing oxidative stress, enhancing neurotransmission, and reducing inflammation. [14-16]
  12. In mice, ginsenoside Rg3 (25-200 mg/kg) reversed scopolamine-induced memory impairment and learning deficits. [17]
  13. In rats exposed to chronic unpredictable stress, ginsenoside Rg3 (20 and 40 mg/kg) produced anti-anxiety effects. [18]

B. Lowers the Risk of Heart Disease

Man clutching his chest in distress, possibly experiencing a heart attack.

Studies suggest that ginsenoside Rg3 offers cardioprotective effects:

  1. In rats, ginsenoside Rg3 administration protected against heart impairment. [19]
  2. In mice with heart injury, ginsenoside Rg3 treatment prevented the development of heart attack. [20]
  3. In rats, ginsenoside Rg3 delayed the progression of cardiovascular disease (CVD). [21]
  4. In mice with isoproterenol-induced myocardial infarction (heart attack), ginsenoside Rg3 protected against further heart injury. [22]
  5. In rats with insufficient blood flow to the heart, ginsenoside Rg3 improved cardiac function by attenuating programmed cell death (apoptosis) and inflammation. [23-25]
  6. In hypertensive rats, ginsenoside Rg3 exerted cardioprotective effects. [26]
  7. In rats, ginsenoside Rg3 improved cardiac adaptations to exercise by regulating mitochondria dynamic remodeling and enhancing the quantity and quality of mitochondria. [27]
  8. A test tube study found that ginsenoside Rg3 significantly inhibited collagen-induced platelet aggregation, suggesting that it can help prevent blood clot formation in the heart. [28]
  9. In rabbits, ginsenoside Rg3 alleviated antithyroid cancer drug vandetanib-induced QT interval prolongation (abnormal heart rhythm. [29]
  10. A study found that ginsenoside Rg3 mitigated doxorubicin-induced cardiotoxicity and enhanced its anticancer efficacy. [30]
  11. In mice with narrowing of the heart arteries, ginsenoside Rg3 improved cardiac function by restoring normal heart signals. [31]

C. Lowers Blood Pressure

Doctor measuring a man's blood pressure with a sphygmomanometer in a clinical setting.

Evidence shows that Rg3 has antihypertensive properties:

  1. In hypertensive rats, ginsenoside Rg3 lowered blood pressure by attenuating renin-angiotensin system (RAS) activity. [26]
  2. In rats, daily oral administration of ginsenoside Rg3 lowered systolic and diastolic blood pressure. [32]
  3. A review of several studies showed that ginsenoside Rg3 is beneficial in treating hypertensive patients. [33]

D. Boosts Immune Function

Ginsenoside Rg3 Boosts Immune Function

Studies report that Rg3 also has immune-boosting properties:

  1. In an animal study, treatment with ginsenoside Rg3 has been shown to protect the animals from the lethality of the H1N1 virus. [34]
  2. In mice, ginsenoside Rg3 treatment stimulated an immune response by boosting the levels of specific immune cells such as immunoglobulin G. [35-36]
  3. In mouse B cells, treatment with ginsenoside Rg3 has been shown to increase the levels of immunoglobulin A. [37]  
  4. A cell study found that ginsenoside Rg3 inhibited Th17 differentiation and Th17-mediated neuroinflammation, suggesting that it can help treat Th17-related autoimmune diseases. [38]
  5. In mice with hepatocellular carcinoma, a specific type of liver cancer, ginsenoside Rg3 treatment enhanced cellular immunity. This improvement may be attributed to the stimulation of lymphocytes, Th1-type cytokines interleukin-2, and interferon-γ levels. Studies on hepatocellular carcinoma further highlight the potential therapeutic applications of ginsenoside Rg3 in addressing liver cancer or liver-related malignancies. [39]

E. Helps Lose Weight

Confident woman measuring her waistline with a tape measure, symbolizing successful weight loss and a healthy lifestyle.

Evidence shows that ginsenoside Rg3 can help promote fat loss. Furthermore, there’s increasing interest in exploring the potential of ginsenoside Rg3 for weight loss, given its apparent ability to target fat cells and enhance metabolic functions.

  1. A review of mice studies suggested that ginsenoside Rg3 could potentially reduce body fat percentage. [40]
  2. A study in obese mice showed that ginsenoside Rg3 treatment resulted in better metabolism. [41]
  3. In mice fed with a high-fat diet, ginsenoside Rg3 treatment for 8 weeks significantly reduced body weight by promoting white fat burning. [42]

F. Accelerates Wound Healing

A doctor checking to see if a wound is healing or infected.

There’s also a good deal of evidence supporting the beneficial effects of ginsenoside Rg3 on wound healing. Some studies have pointed out that ginsenoside Rg3 can influence the activity of the epidermal growth factor receptor (EGFR), which plays a key role in tissue repair and regeneration. Furthermore, by modulating the epidermal growth factor receptor, ginsenoside Rg3 might enhance the cellular mechanisms associated with wound recovery and skin restoration:

  1. Studies showed that ginsenoside Rg3 consumption can help improve wound healing through its anti-inflammatory effects. [43-44]
  2. Studies also reported that ginsenoside Rg3 can help prevent the formation of raised scars after an injury. [45-47]
  3. A study also found that ginsenoside Rg3 can help prevent keloid scar formation by promoting collagen synthesis. [48]
  4. In animals with experimental wounds, ginsenoside Rg3 induced the repair of tissue damage in the early stage and inhibited scar formation in the late stage of wound healing. [49]

G. Prevents Cancer

Doctor holding a small board displaying the words 'Cancer Prevention', emphasizing the importance of proactive health measures.

Ginsenoside Rg3, a naturally occurring compound found in certain species of the ginseng plant, has been studied extensively for its anti-cancer properties. It operates through multiple pathways to prevent the development and progression of cancer. One of the primary mechanisms is its ability to induce apoptosis, or programmed cell death, in cancerous cells. This not only curtails the growth of tumors but also prevents the abnormal cells from replicating and spreading, such as in the case of ovarian cancer metastasis.

Additionally, Rg3 has been observed to inhibit angiogenesis—the process by which tumors develop their blood supply—which is crucial for their growth and metastasis. By targeting these fundamental aspects of cancer cell survival and expansion, ginsenoside Rg3 demonstrates a robust defense against the establishment and progression of various cancers including inhibiting cancer cell proliferation.

Moreover, ginsenoside Rg3 enhances the efficacy of chemotherapy while potentially reducing its adverse side effects. It appears to sensitize cancer cells to the cytotoxic effects of chemotherapeutic drugs, thereby requiring lower doses for the same therapeutic effect, which could lead to a reduction in the drugs’ toxic impacts on healthy cells.

Furthermore, Rg3 exerts a modulatory influence on the immune system, boosting the body’s natural defense mechanisms to identify and destroy cancer cells via an enhanced immune response. This modulation can lead to a reduction in cancer cell proliferation, as the immune system becomes more efficient at targeting and eliminating malignant cells. By fostering an environment that is less conducive to cancer growth and by amplifying the body’s inherent cancer-fighting capabilities, ginsenoside Rg3 presents a multi-faceted approach to cancer prevention, warranting further investigation and integration into cancer treatment regimens.

A substantial body of high-quality research indicates that ginsenoside Rg3 exhibits potent anti-cancer effects against various human cancer cells. In particular, it has shown activity against gallbladder cancer cells by disrupting their growth signals. The compound has been found to be effective in preventing the proliferation and survival of colon cancer cell lines, where it interferes with cancer cell metabolism and DNA replication.

Studies involving gallbladder cancer cells have further elucidated the pathways through which ginsenoside Rg3 exerts its effects, revealing the compound’s capacity to inhibit cancer cells via modulation of signal transduction and gene expression. Additionally, its therapeutic effects on cancer mda mb 231 cells highlight its promise in targeting aggressive forms of breast cancer. By stymieing the migration and invasiveness of these cells, ginsenoside Rg3 contributes to a broader anti-cancer strategy.

Research has also focused on the way ginsenoside Rg3 tackles thyroid cancer metastasis, where it has been seen to prevent the spread of cancerous cells, further indicating its potential as a valuable adjunct in cancer treatment protocols. The comprehensive impact of ginsenoside Rg3 on cancer mda mb 231 cells, colon cancer cell lines, and other human cancer cells underlines its significance as a powerful compound in the fight against cancer.

  1. Research revealed that ginsenoside Rg3 can act against tumor cells, exhibiting the capability to inhibit tumor growth. In multiple studies, its effects on tumor cells were profound, especially in colon cancer cells, where it was observed to have strong anti-tumor properties. This compound not only hampers tumor growth but also notably targets the growth, proliferation, and colon cancer cell migration, making it a significant find in cancer research. It provides a basis for developing potential therapeutic agents that can inhibit the advancement and spread of cancer, particularly in cases of colon cancer. [50]
  2. Another study highlighted the potential effects of rg3 on cancer prevention, showing that ginsenoside Rg3 can assist in preventing esophageal cancer, including esophageal squamous cell carcinoma. Specifically, the effects of rg3 on certain cancer cell mechanisms, especially in esophageal squamous cell carcinoma, helped inhibit the proliferation of these harmful cells. Furthermore, it was observed that this compound can significantly diminish the growth of prostate cancer cells, providing another promising avenue in the fight against cancer cell growth. [51]
  3. In mice-bearing H460 lung cancer cells, a type of non-small cell lung cancer, and hypoxic lung cancer cells, a 28-day oral regimen with ginsenoside Rg3 at 100 mg/kg notably reduced tumor growth. Ginsenoside Rg3 inhibits the progression and growth of these specific cancer types. Further research has indicated that ginsenoside Rg3 can be particularly effective against non-small cell lung cancers, which constitute a significant proportion of lung cancer cases. This efficacy stems from the ability of ginsenoside Rg3 to inhibit tumor cell proliferation and migration. Furthermore, ginsenoside Rg3 inhibits several mechanisms that these cancer cells use to thrive and spread. [52]
  4. Human esophageal cancer cells, human gastric cancer cells, and even other types of cancer cells, including gastric cancer cells, witnessed protective benefits from ginsenoside Rg3. Ginsenoside Rg3 inhibits the growth mechanisms in esophageal cancer cells, promoting programmed cell death. Similarly, studies on human gastric cancer cell lines showed that ginsenoside Rg3 slows down cancer cell growth, offering potential therapeutic benefits for those with gastric malignancies. Furthermore, ginsenoside Rg3 shows promise in targeting the specific pathways that contribute to human gastric cancer cell growth. Additional research is needed to uncover more about its potential against various stages of gastric cancer. [53]
  5. Numerous research papers have suggested that ginsenoside Rg3 can amplify the therapeutic impact of anti-cancer drugs while concurrently decreasing their side effects. This was especially observed in ovarian cancer cells and human breast cancer samples. In relation to human breast cancer cells, ginsenoside Rg3 showed promise in inhibiting growth and progression. Some studies focused on human breast cancer MDA samples and breast cancer MDA MB lines, revealing potential molecular targets for ginsenoside Rg3’s action. Notably, metastatic breast cancer, which is a form of advanced breast cancer that spreads to other parts of the body, has been another area of investigation for ginsenoside Rg3. Some studies have indicated its potential efficacy against triple-negative breast cancer, a particularly aggressive form of breast cancer that lacks the usual receptors targeted by many treatments. Considering the challenges of treating metastatic breast cancer, researchers are hopeful about the benefits of ginsenoside Rg3. Research is ongoing to explore how ginsenoside Rg3 interacts with triple-negative breast cancer cells and its potential as a therapeutic agent for this challenging condition. [54-64]
  6. In experiments with human colorectal cancer cells, ginsenoside Rg3 thwarted cancer growth and its subsequent progression. This compound showed a marked ability to inhibit colorectal tumor growth, demonstrating its potential therapeutic effects. Its effects were also seen in colon cancer cells, where it further suppressed colorectal tumor growth, and in small-cell lung cancer specimens. [65-68]
  7. For patients diagnosed with lung cancer, including both non-small cell lung and small cell lung cancer, ginsenoside Rg3 not only extended overall survival but also obstructed the growth and viability of cancer cells. Studies specifically looking into non-small cell lung cancer also highlighted the potential benefits of ginsenoside Rg3 in enhancing treatment outcomes. [69-71]
  8. Patients and animals afflicted with breast cancer, specifically human breast cancer mda, demonstrated promising results upon treatment with ginsenoside Rg3. When analyzing mda mb 231 cells, a specific line of breast cancer cells, there was a notable response to ginsenoside Rg3 treatment. In the context of metastatic breast cancer, especially involving mda mb 231 cells, ginsenoside Rg3 showcased potential in combating the spread of the disease. Studies focusing on breast cancer MDA mb, including evaluations on mda mb 231 cells, found a noticeable reduction in tumor expansion. Furthermore, it triggered programmed cell death and delayed the progression of breast cancer. [72-74]
  9. There’s evidence that ginsenoside Rg3 stunts the proliferation of malignant cells, demonstrating a strong inhibitory effect of ginsenoside on their growth. Particularly, in prostate cancer cells and hypoxic lung cancer cells, the inhibitory effect of ginsenoside plays a crucial role by altering the immunosuppressive microenvironment. [75]
  10. In mouse studies, ginsenoside Rg3 obstructed the migration and invasion of liver cancer cells, including hepatocellular carcinoma, by augmenting the protein ARHGAP9. This compound has shown promise in inhibiting the growth of cancer cell, particularly in the liver, where hepatocellular carcinoma is a prevalent type. Simultaneously, its effectiveness was noted against small-cell lung cancer types. Research continues to examine its impact on various cancer cell lines, including hepatocellular carcinoma, to understand its full therapeutic potential. [76]
  11. One cell study shed light on how ginsenoside Rg3 arrested the growth and dissemination of several thyroid cancer cell lines. Notably, this research also indicated that the compound was effective in targeting the cancer cell’s metabolic pathways, hindering their proliferation. Moreover, ginsenoside Rg3 was found to be particularly potent against prostate and colon cancer cells, suggesting its broad-spectrum activity against various cancer cell types. [77]
  12. It’s worth noting that ginsenoside Rg3 has also been documented to restrict the growth dynamics of prostate cancer cell line, small cell lung cancer samples, and non-small cell lung cancer. In particular, rg3 inhibits the aggressive behavior of these cancer types. This suggests that rg3 inhibits not only the growth but also the metastatic potential of prostate cancer cells, non-small cell lung cancer cells, and other malignant cells. The anti-cancer effects of ginsenoside Rg3 on these cells have gained significant attention in recent research. [78]
  13. In a laboratory model of ovarian cancer, including detailed studies on ovarian cancer cells, the effects of ginsenoside Rg3 were thoroughly examined, revealing the effects of Rg3 in impeding metastasis. Specifically, ginsenoside Rg3 showed a notable capacity to inhibit the progression and dissemination of ovarian cancer cells, suggesting its potential as a promising adjunct in ovarian cancer treatment. This compound’s action against ovarian cancer could offer a new avenue for therapeutic strategies. Additionally, the impact of ginsenoside Rg3 extended to human breast cancer samples, where it effectively thwarted the growth and proliferation of cancer cells. The consistent efficacy across different types of cancer, including ovarian cancer, underscores the potential of ginsenoside Rg3 as a valuable component in comprehensive cancer treatment protocols. [79]

H. Improves Mood

Radiant woman with a broad smile, eyes sparkling with joy, symbolizing an uplifted and improved mood.

Studies show that Rg3 also has antidepressant effects. Ginsenoside Rg3 induces positive changes in mood by modulating neurotransmitter levels in the brain. Moreover, research suggests that ginsenoside Rg3 induces a protective effect against stress-related disorders, further highlighting its potential benefits in mental health.

  1. In rats exposed to chronic unpredictable stress, ginsenoside Rg3 administration at 20 and 40 mg/kg produced anti-anxiety effects. [18]
  2. In a mouse study, ginsenoside Rg3 induced positive effects on immunoregulation, which in turn helped in reducing signs of depression. Researchers believe that the benefits might be linked to the changes ginsenoside Rg3 induced in the immune system’s response, impacting brain functions associated with mood. [80]
  3. A review of studies highlighted the potent effect of Rg3 in traditional herbal remedies. It showed that ginsenoside Rg3 treatment, particularly the effect of Rg3 on neuroprotective functions, reduced depressive symptoms in patients with low mood. Some researchers believe the effect of Rg3 on brain pathways could be a potential reason behind its mood-enhancing capabilities. Furthermore, considering the overall effect of Rg3 in holistic health, its role in mental well-being is increasingly being recognized. [81]

I. Improves Blood Sugar Levels and Treats Diabetic Symptoms

Ginsenoside Rg3 has been extensively studied for its therapeutic properties. Research indicates that ginsenoside Rg3 induces positive changes in metabolic functions, leading to improved blood sugar regulation. Furthermore, ginsenoside Rg3 induces enhancements in the way the body utilizes the insulin hormone and ensures effective blood sugar transport. This suggests its potential in treating symptoms of diabetes and maintaining optimal blood sugar levels:

  1. In mice, ginsenoside Rg3 suppressed the blood sugar levels from rising by enhancing insulin secretion 30 minutes after administration. [82]
  2. A study found that ginsenoside Rg3 enhanced the transport of blood sugar within the cells. [83]
  3. In type 2 diabetic mice, ginsenoside Rg3 lowered blood sugar by increasing insulin levels. [84]
  4. In diabetic rats, ginsenoside Rg3 protected against lung injury caused by high blood sugar levels. [85]   
  5. In diabetic rat models, ginsenoside Rg3 protected the kidney against damage due to inflammation. [86]
  6. A cell study reported that ginsenoside Rg3 improved insulin signaling and blood sugar uptake. [87]
  7. In western diet-fed mice, ginsenoside Rg3 alleviated diabetic complications such as elevated blood sugar, triglyceride, and low-density lipoprotein (bad cholesterol) levels. [88]
  8. In animal models of diabetes, ginsenoside Rg3 protected the insulin-producing cells of the pancreas against cell death. [89-90]   
  9. In diabetic rats, ginsenoside Rg3 significantly ameliorated kidney dysfunction. [91] 
  10. In mice fed with a high-fat diet, ginsenoside Rg3 ameliorated obesity-induced insulin resistance. [92]
  11. In a mice model with diabetic atherosclerosis (plaque formation within the heart arteries), ginsenoside Rg3 inhibited the migration of the plaques. [93] 
  12. In mice, ginsenoside Rg3 significantly ameliorated insulin resistance through activation of the AMPK pathway. [94]
  13. In streptozotocin-induced diabetic rats, ginsenoside Rg3 improved erectile function. [95]

Associated Side Effects of Ginsenoside Rg3

Ginsenoside Rg3 side effects are very uncommon. There have been some side effects associated with the use of this drug wherein the patient had one of the issues listed below at some point while being on ginsenoside Rg3. However, these side effects weren’t confirmed to be associated with the treatment and could have been a coincidence and not related to the use of ginsenoside Rg3. Despite this, it was listed as a side effect associated with ginsenoside Rg3 even though these associated side effects are very uncommon.  

Side effects associated with ginsenoside Rg3 may include the following:

  • Decreased appetite
  • Diarrhea
  • Nausea
  • Rashes

Ginsenoside Rg3 Dosage

The appropriate dosage of Ginsenoside Rg3 can vary widely depending on several factors, including the age, health status of the individual, the form of the product, and the purpose for which it is being used.

For clinical applications, especially in cancer treatment, the dosages can vary based on the type and stage of cancer, and are often determined by the healthcare provider within the context of a clinical trial or a specialized treatment protocol. For instance, doses in the range of 20-60 mg per day have been used in some clinical studies for anti-cancer purposes, where rg3 induced apoptotic cell death is a desired outcome to prevent the proliferation of cancerous cells.

For general health supplements, the dosages might be lower. However, there is no universally accepted standard dose for Rg3 due to the variability in ginseng preparations and the concentration of active components.

Research indicates that Ginsenoside Rg3 inhibits colorectal tumor growth by interfering with cell growth pathways, thereby offering a therapeutic advantage in colorectal cancer management. The compound’s ability to inhibit colorectal tumor growth has been a focus of numerous studies, reflecting its potential role in integrative oncology. Additionally, the influence of Ginsenoside Rg3 on cell growth does not limit its action to malignant cells alone; its impact on normal cell growth must be considered to avoid unintended consequences on healthy tissues.

It’s critical to note that natural products are not always necessarily safe and dosages can be important. Just because ginsenosides are natural compounds, it does not mean that they can be taken in any amount without potential risks. Overdosing on Ginsenoside Rg3 can lead to side effects such as gastrointestinal issues, sleep problems, and possible interactions with other medications, which may impact cell growth in non-targeted tissues.

Before starting any new supplement, including Ginsenoside Rg3, it’s best to consult with a healthcare provider who can provide guidance based on your specific health needs and conditions. They can also monitor for potential interactions with other medications and advise on the correct dosage for your situation, to ensure that cell growth is regulated safely and effectively.

Ginsenoside Rg3 Supplement Availability

Ginsenoside Rg3 supplements are typically found in specialty health food stores, online supplement retailers, or stores that specialize in herbal and traditional medicines. Availability can vary based on your region and local regulations regarding supplements.

Here’s what to consider when looking for ginsenoside Rg3 supplements:

  • Quality and Purity: Look for supplements that have been tested for quality and purity. Some companies provide certificates of analysis (COAs) for their products.
  • Form: Ginsenoside Rg3 is available in various forms, such as capsules, tablets, powders, and sometimes as a liquid extract.
  • Concentration: Pay attention to the concentration of Rg3, as this can vary significantly between products.
  • Source: Look for products that specify the source of the ginsenoside Rg3, as this can affect the type and purity of the compound.
  • Brand Reputation: Choose brands with good reputations and reviews from consumers.
  • Legal Status: In some countries, the sale of certain supplements may be regulated or restricted, so check the legal status of ginsenoside Rg3 in your country.
  • Consult Healthcare Providers: Before taking any new supplement, it’s always best to consult with a healthcare provider, especially if you have underlying health conditions or are taking other medications.

Ginsenoside Rg3 Interactions with Drugs and Nutrients

Interactions with Drugs

Ginsenoside Rg3, like many bioactive compounds derived from herbal medicines, can interact with pharmaceutical drugs, often influencing their pharmacokinetics or pharmacodynamics. For instance, its modulatory effects on liver enzymes such as cytochrome P450 can affect the metabolism of certain drugs, potentially leading to either an increase or decrease in their active levels in the bloodstream. This means that medications with a narrow therapeutic index, such as warfarin or some antiepileptics, may require close monitoring and dosage adjustments when taken concurrently with ginsenoside Rg3 supplements. Additionally, given its potential antiplatelet and anticoagulant effects, there might be an increased risk of bleeding when ginsenoside Rg3 is combined with anticoagulant drugs like heparin or antiplatelet agents such as aspirin.

Interactions with Nutrients

The interactions between ginsenoside Rg3 and various nutrients can also be significant, particularly in the realms of absorption and bioavailability. Certain minerals, for example, may compete with ginsenoside Rg3 for absorption in the gastrointestinal tract, potentially reducing the efficacy of either the nutrient or the ginsenoside. Conversely, some vitamins (like Vitamin C) might enhance the absorption of ginsenosides. On the other hand, dietary fiber could bind to ginsenoside Rg3, thereby decreasing its bioavailability. Therefore, timing and dietary composition might be crucial when consuming ginsenoside Rg3 to maximize its benefits without compromising the nutritional value of one’s diet.

Potential for Adverse Interactions

Despite its therapeutic properties, the potential for adverse interactions between ginsenoside Rg3 and other drugs or nutrients underscores the necessity for professional oversight. Individuals taking prescription medications for chronic conditions, such as diabetes, hypertension, or mood disorders, should consult healthcare providers before starting any ginsenoside Rg3 supplementation. This is particularly important because ginsenoside Rg3 might alter the effects of hypoglycemic drugs or antihypertensive agents. Moreover, as the research into ginsenoside Rg3 is still evolving, health professionals must stay informed about the latest findings to guide their patients appropriately in the context of polypharmacy and complex dietary habits.

Share This Page

FAQ

What is the effect of ginsenosides?

Ginsenosides, the primary active compounds found in ginseng, have garnered attention for their range of therapeutic effects. Research has particularly highlighted that ginsenoside Rg3 inhibits the growth and metastasis of certain cancer cells, demonstrating a potential role in oncology. With its anti-inflammatory, antioxidant, and neuroprotective properties, ginsenoside Rg3 inhibits not only the proliferation of malignancies but also mediates protective mechanisms in neuronal and cardiovascular tissues.

What is the antioxidant activity of ginsenosides?

Ginsenosides, particularly due to the effect of ginsenoside Rg3, have strong antioxidant activity. This activity, stemming from the effect of ginsenoside Rg3, means they can neutralize free radicals in the body. By reducing oxidative stress and potential cellular damage, the effect of ginsenoside Rg3 demonstrates its importance in the overall benefits of ginsenosides. Additionally, this reduction in oxidative stress may inhibit the proliferation of tumor cells, indicating a potential for ginsenoside Rg3 in contributing to cancer prevention strategies.

What is 20 s ginsenoside Rg3?

20(S)-ginsenoside Rg3 is one of the stereoisomers of ginsenoside Rg3 found in the ginseng plant. Ginsenosides, the major active ingredients of ginseng, are a diverse group of steroidal saponins. They can exist in different stereoisomeric forms because of the difference in spatial arrangement around their chiral centers. Specifically, ginsenoside Rg3 has two stereoisomers: 20(S)-ginsenoside Rg3 and 20(R)-ginsenoside Rg3.

Among the two, 20(S)-ginsenoside Rg3 is often reported to have stronger pharmacological effects. Studies have shown that this compound possesses various therapeutic properties, including anti-cancer, anti-inflammatory, cardioprotective, and neuroprotective activities.

What is the solubility of ginsenosides?

Ginsenosides are mainly soluble in water and alcohol, but their solubility can vary based on their specific structure and type.

What happens when you take ginseng every day?

Taking ginseng daily can help boost energy levels, improve cognitive function, and enhance the immune system. However, excessive or long-term use may lead to side effects.

How does ginseng help the brain?

Ginseng and its components, especially ginsenosides, have been shown to improve cognitive function, protect nerve cells against oxidative stress and inflammation, and potentially aid in memory enhancement.

What are the side effects of taking ginseng vitamins?

Potential side effects of ginseng, especially when consumed in the form of red ginseng extract, include headaches, digestive problems, sleep disturbances, nervousness, and elevated blood pressure. It’s essential to understand the source and formulation of the ginseng product being consumed.

How do you feel after taking ginseng?

Most people report feeling more energetic and alert after taking ginseng. The compound ginsenoside Rg3 promotes increased energy and vitality in many individuals. Additionally, ginsenoside Rg3 promotes better mental clarity, which could be a reason behind the heightened alertness. With its potential benefits, ginsenoside Rg3 promotes overall well-being when consumed. It’s not just the ginseng, but specifically how ginsenoside Rg3 promotes these positive effects that have caught the attention of many researchers.

What are the sources of ginsenosides?

The primary source of ginsenosides is the ginseng plant, especially the roots.

How much ginsenosides per day?

The recommended daily dose varies, but generally, it’s between 1 to 2 grams of raw ginseng root. However, always consult with a healthcare professional for personalized advice.

Who should not take ginseng?

People with high blood pressure, pregnant and nursing women, and those taking certain medications (like blood thinners) should avoid ginseng or consult with a doctor before use.

Is ginseng better in the morning or night?

Ginseng is often recommended in the morning or early afternoon due to its energizing effects which might interfere with sleep if taken at night.

How many times a week should I take ginseng?

This varies based on personal needs and the advice of a healthcare provider, but many people take ginseng daily or at least several times a week.

What are the long-term side effects of ginseng?

Long term use of ginseng can lead to side effects like hormonal imbalances, insomnia, elevated blood pressure, and digestive issues.

Does ginseng work quickly?

The effects of ginseng can be felt shortly after taking it, but for some benefits, consistent and prolonged use might be required. Among these long-term benefits, studies have suggested that an active component of ginseng, ginsenoside Rg3, inhibits colorectal tumor growth. This indicates that regular consumption of ginseng, with its Rg3 content, could potentially contribute to colorectal health over time.

Which ginseng is best?

The “best” ginseng depends on the desired effect. Panax ginseng is often used for energy and cognitive benefits, while American ginseng might be preferred for immune support.

Is ginseng good or bad for the heart?

Ginseng has cardioprotective effects and can be beneficial for heart health, but excessive intake can increase blood pressure. Always consult with a doctor.

What is the best time of day to take ginseng?

Morning or early afternoon is usually recommended to avoid potential sleep disturbances.

Does ginseng affect your kidneys?

While ginseng has been used traditionally to support kidney health, excessive or prolonged intake can stress the kidneys. Consultation with a doctor is essential.

How much ginseng is safe daily?

Typically, 1 to 2 grams of raw ginseng root is considered safe, but the appropriate amount varies by individual and product concentration.

Does ginseng detox your body?

Ginseng has antioxidant properties that can support the body’s natural detoxification processes.

Are ginsenosides steroids?

Ginsenosides are steroid-like compounds, but they’re not steroids in the traditional sense.

What percentage of ginseng is ginsenosides?

The percentage can vary, but typically, dried ginseng root contains 2-3% ginsenosides.

Which ginseng has the most ginsenosides?

Korean Red Ginseng, a form of Panax ginseng, is often considered to have the highest ginsenoside content.

What ginseng is best for brain health?

Panax ginseng, especially Korean Red Ginseng, is commonly recommended for cognitive benefits.

Are ginsenosides saponins?

Yes, ginsenosides are a type of saponin found in ginseng plants.

Does ginseng grow naturally?

Yes, ginseng grows naturally in various regions, including North America and Asia, but cultivated varieties also exist.

Are ginsenosides polysaccharides?

No, ginsenosides are saponins. Ginseng does contain beneficial polysaccharides, but these are distinct from ginsenosides.

Does ginseng affect the immune system?

Yes, ginseng can modulate and boost the immune system.

 

Can I take ginseng with other vitamins?

Generally, ginseng can be taken with vitamins, but always consult with a healthcare provider regarding potential interactions.

Is ginseng bad for blood pressure?

Ginseng can affect blood pressure. Some people experience an increase, so those with hypertension should be cautious and consult with a doctor.

Can I take ginseng on an empty stomach?

Ginseng can be taken on an empty stomach, but some people may experience stomach upset and prefer to take it with food.

Does ginseng interact with any medications?

Ginseng can be taken on an empty stomach, but some people may experience stomach upset and prefer to take it with food.

Does ginseng interact with any medications?

Yes, ginseng can interact with medications, especially blood thinners, diabetes medications, and antidepressants. Always consult with a healthcare provider.

Is ginseng acidic or alkaline?

Ginseng is generally considered slightly acidic.

Is ginseng good for females?

Yes, ginseng can offer benefits for females, including energy boosts and hormonal balance. However, specific effects can vary by individual.

Which ginseng is best for anti-aging?

Korean Red Ginseng is often touted for its anti-aging benefits due to its high ginsenoside content.

Is ginseng good for acid reflux?

There’s limited evidence on this, and while some believe it may help, others find it can exacerbate symptoms. Always consult with a doctor.

Can ginseng cause heart palpitations?

In some individuals, excessive intake can cause side effects including heart palpitations.

How many times a week should I take ginseng?

The frequency can vary based on personal needs and advice from a healthcare provider, but many take ginseng daily or several times a week.

Is ginseng good for your face?

Ginseng has anti-aging and antioxidant properties that can be beneficial for skin health.

Is ginseng a blood thinner?

Ginseng can interact with blood-thinning medications and may have blood-thinning effects on its own. Always consult with a healthcare provider.

Is ginseng good for creatinine?

There’s limited research, but some studies suggest ginseng might help reduce creatinine levels in individuals with kidney issues.

Is ginseng safe for liver?

Moderate consumption of ginseng is generally safe, but excessive or prolonged intake can stress the liver.

Does ginseng increase uric acid?

There’s limited evidence on this, and more research is needed to draw conclusions.

What is the best time of day to take ginseng?

Morning or early afternoon is usually recommended due to its energizing effects.

How does ginseng help sleep?

While ginseng can be energizing, some forms, like American ginseng, may have calming effects that can potentially aid sleep.

How long does it take for ginseng to work?

The effects of ginseng can be felt shortly after intake, with initial energizing effects often reported. However, for some benefits, such as capturing circulating tumor cells—a process critical for limiting the spread of cancer—consistent use over weeks or months might be required. Ginseng’s active compounds, including ginsenosides, have been studied for their ability to interfere with cancer progression because they induce apoptosis of human cancer cells. This programmed cell death is essential for eliminating malignant cells and preventing the development of tumors. Therefore, the full spectrum of ginseng’s therapeutic effects, especially in the context of cancer prevention and treatment, often emerges with long-term use.

Why do athletes take ginseng?

Athletes often take ginseng for its energy-boosting, anti-fatigue, and potential performance-enhancing properties.

How many times a week should I take ginseng?

The frequency can vary, but many individuals take ginseng daily or at least several times a week, based on personal needs and the advice of a healthcare provider. Additionally, research into the benefits of ginseng has shown that one of its active components, ginsenoside Rg3, induces apoptosis of human cancer cells, which may be beneficial in developing treatments for various cancers.

What are the potential benefits of 20(S)-ginsenoside Rg3?

20(S)-ginsenoside Rg3 has been researched for its various therapeutic properties. These include anti-cancer activities, cardioprotective effects, anti-inflammatory benefits, and neuroprotective properties. It is often reported to possess stronger pharmacological effects than its isomeric counterpart.

How does 20(S)-ginsenoside Rg3 differ from 20(R)-ginsenoside Rg3?

Both 20(S)-ginsenoside Rg3 and 20(R)-ginsenoside Rg3 are stereoisomers, meaning they have the same molecular formula but differ in the spatial arrangement of their atoms. Among the two, 20(S)-ginsenoside Rg3 is often considered to have more potent pharmacological activities based on various studies.

How is 20(S)-ginsenoside Rg3 sourced?

20(S)-ginsenoside Rg3 is naturally sourced from certain species of the ginseng plant, particularly from its roots. It can be extracted and purified using various techniques to obtain a concentrated form suitable for research or therapeutic applications.

Are there any side effects associated with 20(S)-ginsenoside Rg3 consumption?

While 20(S)-ginsenoside Rg3 is generally considered safe when consumed within recommended dosages, like any compound, excessive or inappropriate use might lead to adverse effects. It’s crucial to follow recommended guidelines or consult with a healthcare professional before starting any supplementation.

Can 20(S)-ginsenoside Rg3 be used in combination with other treatments?

Preliminary research indicates that 20(S)-ginsenoside Rg3 can enhance the therapeutic effects of certain treatments, particularly by inhibiting cell growth in the context of cancer therapies. Ginsenoside Rg3 attenuates the proliferation of malignant cells, offering a potential adjunctive benefit to conventional treatments by potentially slowing tumor metastasis. Moreover, ginsenoside Rg3 attenuates the aggressive nature of cancer cells, which might complement the action of other therapeutic agents aimed at mitigating tumor metastasis. However, it is crucial to always consult with a healthcare professional before combining it with other treatments to ensure safety and efficacy.

How does 20(S)-ginsenoside Rg3 impact immune function?

Studies suggest that 20(S)-ginsenoside Rg3, often referred to as 20 S RG3, may modulate the immune system by enhancing the activity of certain immune cells, thereby potentially bolstering the body’s defense mechanisms against pathogens and diseases. The presence of 20 S RG3 in ginseng is believed to be a key factor in its health benefits. Additionally, 20 S RG3 has been the subject of numerous studies aiming to harness its therapeutic properties for improving immune function.

Ongoing research is delving deeper into how 20 S RG3 can be utilized in immune system enhancement. The potential for 20 S RG3 to contribute to novel treatments in immunotherapy is an exciting development in the field of medicine. As scientists continue to study 20 S RG3, they are uncovering more about its role in regulating both innate and adaptive immune responses.

It’s also worth noting that 20 S RG3 might have synergistic effects when combined with other immune-boosting compounds, although such combinations would require careful study to understand their interactions fully. Lastly, the potential of 20 S RG3 in improving vaccine efficacy is another area of interest, providing a promising avenue for further investigation.

Reference

  1. Bao HY, Zhang J, Yeo SJ, Myung CS, Kim HM, Kim JM, Park JH, Cho J, Kang JS. Memory enhancing and neuroprotective effects of selected ginsenosides. Arch Pharm Res. 2005 Mar;28(3):335-42. doi: 10.1007/BF02977802. PMID: 15832823.

  2. Kim, Y. C., Kim, S. R., Markelonis, G. J., and Oh, T. H., Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration.J. Neurosci. Res., 53, 426–432 (1998).

  3. Joo SS, Yoo YM, Ahn BW, Nam SY, Kim YB, Hwang KW, Lee DI. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol Pharm Bull. 2008 Jul;31(7):1392-6. doi: 10.1248/bpb.31.1392. PMID: 18591781.

  4. Park SM, Choi MS, Sohn NW, Shin JW. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. doi: 10.1248/bpb.b12-00393. PMID: 22975507.

  5. Jang SK, Yu JM, Kim ST, Kim GH, Park DW, Lee DI, Joo SS. An Aβ42 uptake and degradation via Rg3 requires an activation of caveolin, clathrin and Aβ-degrading enzymes in microglia. Eur J Pharmacol. 2015 Jul 5;758:1-10. doi: 10.1016/j.ejphar.2015.03.071. Epub 2015 Apr 4. PMID: 25848967.

  6. Available at http://koreascience.or.kr/article/JAKO201201052161301.page.

  7. Lee B, Sur B, Park J, Kim SH, Kwon S, Yeom M, Shim I, Lee H, Hahm DH. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. BiomolTher (Seoul). 2013 Sep 30;21(5):381-90. doi: 10.4062/biomolther.2013.053. PMID: 24244826; PMCID: PMC3825202.

  8. Aalinkeel R, Kutscher HL, Singh A, Cwiklinski K, Khechen N, Schwartz SA, Prasad PN, Mahajan SD. Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential monotherapy for Alzheimer’s disease? J Drug Target. 2018 Feb;26(2):182-193. doi: 10.1080/1061186X.2017.1354002. Epub 2017 Jul 17. PMID: 28697660.

  9. Zhang, Y., Yang, X., Wang, S., & Song, S. (2019). Ginsenoside Rg3 Prevents Cognitive Impairment by Improving Mitochondrial Dysfunction in the Rat Model of Alzheimer’s Disease. Journal of agricultural and food chemistry, 67(36), 10048–10058. https://doi.org/10.1021/acs.jafc.9b03793.

  10. Sheng C, Peng W, Xia ZA, Wang Y, Chen Z, Su N, Wang Z. The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer’s disease: a systematic review. BMC Complement Altern Med. 2015 Oct 24;15:386. doi: 10.1186/s12906-015-0894-y. PMID: 26497388; PMCID: PMC4619356.

  11. Sheng, C., Peng, W., Xia, Z. A., Wang, Y., Chen, Z., Su, N., & Wang, Z. (2015). The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer’s disease: a systematic review. BMC complementary and alternative medicine, 15, 386. https://doi.org/10.1186/s12906-015-0894-y.

  12. Kim, J., Shim, J., Lee, S., Cho, W. H., Hong, E., Lee, J. H., Han, J. S., Lee, H. J., & Lee, K. W. (2016). Rg3-enriched ginseng extract ameliorates scopolamine-induced learning deficits in mice. BMC complementary and alternative medicine, 16, 66. https://doi.org/10.1186/s12906-016-1050-z.

  13. Peña, I. D., Yoon, S. Y., Kim, H. J., Park, S., Hong, E. Y., Ryu, J. H., Park, I. H., & Cheong, J. H. (2014). Effects of ginseol k-g3, an Rg3-enriched fraction, on scopolamine-induced memory impairment and learning deficit in mice. Journal of ginseng research, 38(1), 1–7. https://doi.org/10.1016/j.jgr.2013.11.003.

  14. Bao, H. Y., Zhang, J., Yeo, S. J., Myung, C. S., Kim, H. M., Kim, J. M., Park, J. H., Cho, J., & Kang, J. S. (2005). Memory enhancing and neuroprotective effects of selected ginsenosides. Archives of pharmacal research, 28(3), 335–342. https://doi.org/10.1007/BF02977802.

  15. H. Singh, J. Du, P. Singh, G.T. Mavlonov, T.H. Yi. Development of superparamagnetic iron oxide nanoparticles via direct conjugation with ginsenosides and its in-vitro study. J Photochem Photobiol B: Biol, 185 (2018), pp. 100-110.

  16. Ratan, Z. A., Haidere, M. F., Hong, Y. H., Park, S. H., Lee, J. O., Lee, J., & Cho, J. Y. (2021). Pharmacological potential of ginseng and its major component ginsenosides. Journal of ginseng research, 45(2), 199–210. https://doi.org/10.1016/j.jgr.2020.02.004.

  17. Peña ID, Yoon SY, Kim HJ, Park S, Hong EY, Ryu JH, Park IH, Cheong JH. Effects of ginseol k-g3, an Rg3-enriched fraction, on scopolamine-induced memory impairment and learning deficit in mice. J Ginseng Res. 2014 Jan;38(1):1-7. doi: 10.1016/j.jgr.2013.11.003. Epub 2013 Dec 11. PMID: 24558303; PMCID: PMC3915335.

  18. Xu, J. N., Chen, L. F., Su, J., Liu, Z. L., Chen, J., Lin, Q. F., Mao, W. D., & Shen, D. (2018). The anxiolytic-like effects of ginsenoside Rg3 on chronic unpredictable stress in rats. Scientific reports, 8(1), 7741. https://doi.org/10.1038/s41598-018-26146-5.

  19. Available at https://www.hindawi.com/journals/ecam/2016/6967853/.

  20. Available at https://cdt.amegroups.com/article/view/37868/30147.

  21. Lim, Dong Yoon1; Koh, Young Youp2 PS 04-21 GINSENOSIDE-RG3 INHIBITS CATECHOLAMINE SECRETION FROM THE PERFUSED RAT ADRENAL GLAND, Journal of Hypertension: September 2016 – Volume 34 – Issue – p e138-e139. doi: 10.1097/01.hjh.0000500255.90789.ef.

  22. Sun, G. Z., Meng, F. J., Cai, H. Q., Diao, X. B., Zhang, B., & Bai, X. P. (2020). Ginsenoside Rg3 protects heart against isoproterenol-induced myocardial infarction by activating AMPK mediated autophagy. Cardiovascular diagnosis and therapy, 10(2), 153–160. https://doi.org/10.21037/cdt.2020.01.02.

  23. Zhang, L. P., Jiang, Y. C., Yu, X. F., Xu, H. L., Li, M., Zhao, X. Z., & Sui, D. Y. (2016). Ginsenoside Rg3 Improves Cardiac Function after Myocardial Ischemia/Reperfusion via Attenuating Apoptosis and Inflammation. Evidence-based complementary and alternative medicine : eCAM, 2016, 6967853. https://doi.org/10.1155/2016/6967853.

  24. Wang, Y., Hu, Z., Sun, B., Xu, J., Jiang, J., & Luo, M. (2015). Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B‑cell lymphoma/B‑cell lymphoma‑associated X protein pathway. Molecular medicine reports, 11(6), 4518–4524. https://doi.org/10.3892/mmr.2015.3336.

  25. Tu, C., Wan, B., & Zeng, Y. (2020). Ginsenoside Rg3 alleviates inflammation in a rat model of myocardial infarction via the SIRT1/NF-κB pathway. Experimental and therapeutic medicine, 20(6), 238. https://doi.org/10.3892/etm.2020.9368.

  26. Jiang Y, Li M, Lu Z, Wang Y, Yu X, Sui D, Fu L. Ginsenoside Rg3 induces ginsenoside Rb1-comparable cardioprotective effects independent of reducing blood pressure in spontaneously hypertensive rats. Exp Ther Med. 2017 Nov;14(5):4977-4985. doi: 10.3892/etm.2017.5198. Epub 2017 Sep 22. PMID: 29201202; PMCID: PMC5704305.

  27. Sun, M., Huang, C., Wang, C., Zheng, J., Zhang, P., Xu, Y., Chen, H., & Shen, W. (2013). Ginsenoside Rg3 improves cardiac mitochondrial population quality: mimetic exercise training. Biochemical and biophysical research communications, 441(1), 169–174. https://doi.org/10.1016/j.bbrc.2013.10.039.

  28. Jeong, D., Irfan, M., Kim, S. D., Kim, S., Oh, J. H., Park, C. K., Kim, H. K., & Rhee, M. H. (2017). Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation. Journal of ginseng research, 41(4), 548–555. https://doi.org/10.1016/j.jgr.2016.11.

  29. Zhang, J., Luo, D., Li, F., Li, Z., Gao, X., Qiao, J., Wu, L., & Li, M. (2021). Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib-Induced QT Interval Prolongation. Oxidative medicine and cellular longevity, 2021, 3520034. https://doi.org/10.1155/2021/3520034.

  30. Li, L., Ni, J., Li, M., Chen, J., Han, L., Zhu, Y., Kong, D., Mao, J., Wang, Y., Zhang, B., Zhu, M., Gao, X., & Fan, G. (2017). Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy. Drug delivery, 24(1), 1617–1630. https://doi.org/10.1080/10717544.2017.1391893.

  31. Liu, Z., Bian, X., Gao, W., Su, J., Ma, C., Xiao, X., Yu, T., Zhang, H., Liu, X., & Fan, G. (2021). Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure. Pharmacological research, 172, 105843. https://doi.org/10.1016/j.phrs.2021.105843.

  32. Available at https://journals.sagepub.com/doi/full/10.1177/1934578X19900712.

  33. Lee H, Kong G, Tran Q, Kim C, Park J, Park J. Relationship BetweenGinsenoside Rg3 and Metabolic Syndrome. Front Pharmacol. 2020;11:130. Published 2020 Feb 25. doi:10.3389/fphar.2020.00130.

  34. Available at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171936.

  35. Available from https://academic.oup.com/intimm/article/24/7/465/821288.

  36. Wei, X., Chen, J., Su, F., Su, X., Hu, T., & Hu, S. (2012). Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice. International immunology, 24(7), 465–471. https://doi.org/10.1093/intimm/dxs043.

  37. Park HY, Lee SH, Lee KS, Yoon HK, Yoo YC, Lee J, Choi JE, Kim PH, Park SR. Ginsenoside Rg1 and 20(S)-Rg3 Induce IgA Production by Mouse B Cells. Immune Netw. 2015 Dec;15(6):331-6. doi: 10.4110/in.2015.15.6.331. Epub 2015 Dec 24. PMID: 26770188; PMCID: PMC4700410.

  38. Park, Y. J., Cho, M., Choi, G., Na, H., & Chung, Y. (2020). A Critical Regulation of Th17 Cell Responses and Autoimmune Neuro-Inflammation by Ginsenoside Rg3. Biomolecules, 10(1), 122. https://doi.org/10.3390/biom10010122.

  39. Wu, R., Ru, Q., Chen, L., Ma, B., & Li, C. (2014). Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice. Journal of food science, 79(7), H1430–H1435. https://doi.org/10.1111/1750-3841.12518.

  40. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052819/.

  41. Lee, J., Yoon, S., Lee, S., Lee, M., Jung, H., Kim, T., Yoon, S., Choi, I., Kim, I., Chung, S., Lee, H., Min, J., & Park, Y. (2017). Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ, Journal of Endocrinology, 235(3), 223-235. Retrieved Jan 22, 2021, from https://joe.bioscientifica.com/view/journals/joe/235/3/JOE-17-0233.xml.

  42. Available from https://www.researchgate.net/publication/348453543_Ginsenoside_rg3_reduces_body_weight_by_regulating_fat_content_and_browning_in_obese_mice.

  43. Available at https://www.mdpi.com/2218-273X/10/3/444/htm.

  44. Kang S, Park SJ, Lee AY, Huang J, Chung HY, Im DS. Ginsenoside Rg3 promotes inflammation resolution through M2 macrophage polarization. J Ginseng Res. 2018 Jan;42(1):68-74. doi: 10.1016/j.jgr.2016.12.012. Epub 2017 Jan 1. PMID: 29348724; PMCID: PMC5766702.

  45. Cheng L, Sun X, Hu C, Jin R, Sun B, Shi Y, Zhang L, Cui W, Zhang Y. In vivo inhibition of hypertrophic scars by implantable ginsenoside-Rg3-loaded electrospun fibrous membranes. ActaBiomater. 2013 Dec;9(12):9461-73. doi: 10.1016/j.actbio.2013.07.040. Epub 2013 Aug 9. PMID: 23938200.

  46. Tang M, Wang W, Cheng L, Jin R, Zhang L, Bian W, Zhang Y. The inhibitory effects of 20(R)-ginsenoside Rg3 on the proliferation, angiogenesis, and collagen synthesis of hypertrophic scar derived fibroblasts in vitro. Iran J Basic Med Sci. 2018 Mar;21(3):309-317. doi: 10.22038/ijbms.2018.19451.5153. PMID: 29511498; PMCID: PMC5817175.

  47. Cheng, L., , Sun, X., , Li, B., , Hu, C., , Yang, H., , Zhang, Y., , & Cui, W., (2013). Electrospun Ginsenoside Rg3/poly(lactic-co-glycolic acid) fibers coated with hyaluronic acid for repairing and inhibiting hypertrophic scars. Journal of materials chemistry. B, 1(35), 4428–4437. https://doi.org/10.1039/c3tb20441c.

  48. Cheng L, Sun X, Hu C, Jin R, Sun B, Shi Y, Cui W, Zhang Y. In vivo early intervention and the therapeutic effects of 20(s)-ginsenoside rg3 on hypertrophic scar formation. PLoS One. 2014 Dec 12;9(12):e113640. doi: 10.1371/journal.pone.0113640. PMID: 25502572; PMCID: PMC4264739.

  49. Sun, X., Cheng, L., Zhu, W., Hu, C., Jin, R., Sun, B., Shi, Y., Zhang, Y., & Cui, W. (2014). Use of ginsenoside Rg3-loaded electrospun PLGA fibrous membranes as wound cover induces healing and inhibits hypertrophic scar formation of the skin. Colloids and surfaces. B, Biointerfaces, 115, 61–70. https://doi.org/10.1016/j.colsurfb.2013.11.030.

  50. Tang M, Bian W, Cheng L, Zhang L, Jin R, Wang W, Zhang Y. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways. Int J Mol Med. 2018 Mar;41(3):1487-1499. doi: 10.3892/ijmm.2018.3362. Epub 2018 Jan 4. PMID: 29328420; PMCID: PMC5819908.

  51. Available at https://www.mdpi.com/1420-3049/25/21/4905/pdf.

  52. Park D, Bae DK, Jeon JH, Lee J, Oh N, Yang G, Yang YH, Kim TK, Song J, Lee SH, Song BS, Jeon TH, Kang SJ, Joo SS, Kim SU, Kim YB. Immunopotentiation and antitumor effects of a ginsenosideRg₃-fortified red ginseng preparation in mice bearing H460 lung cancer cells. Environ ToxicolPharmacol. 2011 May;31(3):397-405. doi: 10.1016/j.etap.2011.01.008. Epub 2011 Mar 8. PMID: 21787710.

  53. Liu H, Zhao J, Fu R, Zhu C, Fan D. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway. PLoS One. 2019 May 15;14(5):e0216759. doi: 10.1371/journal.pone.0216759. PMID: 31091245; PMCID: PMC6519821.

  54. Hong, S., Cai, W., Huang, Z., Wang, Y., Mi, X., Huang, Y., Lin, Z., & Chen, X. (2020). Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway. Oncology reports, 44(4), 1333–1342. https://doi.org/10.3892/or.2020.7728.

  55. Kim, D. G., Jung, K. H., Lee, D. G., Yoon, J. H., Choi, K. S., Kwon, S. W., Shen, H. M., Morgan, M. J., Hong, S. S., & Kim, Y. S. (2014). 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget, 5(12), 4438–4451. https://doi.org/10.18632/oncotarget.2034.

  56. Yuan, Z., Jiang, H., Zhu, X., Liu, X., & Li, J. (2017). Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 89, 227–232. https://doi.org/10.1016/j.biopha.2017.02.038.

  57. Pan, L., Zhang, T., Sun, H., & Liu, G. (2019). Ginsenoside Rg3 (Shenyi Capsule) Combined with Chemotherapy for Digestive System Cancer in China: A Meta-Analysis and Systematic Review. Evidence-based complementary and alternative medicine : eCAM, 2019, 2417418. https://doi.org/10.1155/2019/2417418.

  58. Xu, T. M., Xin, Y., Cui, M. H., Jiang, X., & Gu, L. P. (2007). Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chinese medical journal, 120(7), 584–588.

  59. Li, J., Liu, T., Zhao, L., Chen, W., Hou, H., Ye, Z., & Li, X. (2015). Ginsenoside 20(S)‑Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells. International journal of oncology, 46(2), 775–781. https://doi.org/10.3892/ijo.2014.2767.

  60. Kim, S. M., Lee, S. Y., Cho, J. S., Son, S. M., Choi, S. S., Yun, Y. P., Yoo, H. S., Yoon, D. Y., Oh, K. W., Han, S. B., & Hong, J. T. (2010). Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. European journal of pharmacology, 631(1-3), 1–9. https://doi.org/10.1016/j.ejphar.2009.12.018.

  61. Kim, S. M., Lee, S. Y., Yuk, D. Y., Moon, D. C., Choi, S. S., Kim, Y., Han, S. B., Oh, K. W., & Hong, J. T. (2009). Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Archives of pharmacal research, 32(5), 755–765. https://doi.org/10.1007/s12272-009-1515-4.

  62. Liu, T. G., Huang, Y., Cui, D. D., Huang, X. B., Mao, S. H., Ji, L. L., Song, H. B., & Yi, C. (2009). Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC cancer, 9, 250. https://doi.org/10.1186/1471-2407-9-250.

  63. Peng, Z., Wu, W. W., & Yi, P. (2021). The Efficacy of Ginsenoside Rg3 Combined with First-line Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Frontiers in pharmacology, 11, 630825. https://doi.org/10.3389/fphar.2020.630825.

  64. Jiang, Z., Yang, Y., Yang, Y., Zhang, Y., Yue, Z., Pan, Z., & Ren, X. (2017). Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 96, 378–383. https://doi.org/10.1016/j.biopha.2017.09.129.

  65. Tang, Y. C., Zhang, Y., Zhou, J., Zhi, Q., Wu, M. Y., Gong, F. R., Shen, M., Liu, L., Tao, M., Shen, B., Gu, D. M., Yu, J., Xu, M. D., Gao, Y., & Li, W. (2018). Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo. International journal of oncology, 52(1), 127–138. https://doi.org/10.3892/ijo.2017.4183.

  66. He, B. C., Gao, J. L., Luo, X., Luo, J., Shen, J., Wang, L., Zhou, Q., Wang, Y. T., Luu, H. H., Haydon, R. C., Wang, C. Z., Du, W., Yuan, C. S., He, T. C., & Zhang, B. Q. (2011). Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. International journal of oncology, 38(2), 437–445. https://doi.org/10.3892/ijo.2010.858.

  67. Park, E. H., Kim, Y. J., Yamabe, N., Park, S. H., Kim, H. K., Jang, H. J., Kim, J. H., Cheon, G. J., Ham, J., & Kang, K. S. (2014). Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell. Journal of ginseng research, 38(1), 22–27. https://doi.org/10.1016/j.jgr.2013.11.007.

  68. Qiu, R., Qian, F., Wang, X., Li, H., & Wang, L. (2019). Targeted delivery of 20(S)-ginsenoside Rg3-based polypeptide nanoparticles to treat colon cancer. Biomedical microdevices, 21(1), 18. https://doi.org/10.1007/s10544-019-0374-0.

  69. Li, Y., Wang, Y., Niu, K., Chen, X., Xia, L., Lu, D., Kong, R., Chen, Z., Duan, Y., & Sun, J. (2016). Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation. Oncotarget, 7(43), 70535–70545. https://doi.org/10.18632/oncotarget.12059.

  70. Lu, P., Su, W., Miao, Z. H., Niu, H. R., Liu, J., & Hua, Q. L. (2008). Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer. Chinese journal of integrative medicine, 14(1), 33–36. https://doi.org/10.1007/s11655-007-9002-6.

  71. Liu, T., Zuo, L., Guo, D., Chai, X., Xu, J., Cui, Z., Wang, Z., & Hou, C. (2019). Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 120, 109483. https://doi.org/10.1016/j.biopha.2019.109483.

  72. Song, J. H., Eum, D. Y., Park, S. Y., Jin, Y. H., Shim, J. W., Park, S. J., Kim, M. Y., Park, S. J., Heo, K., & Choi, Y. J. (2020). Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells. PloS one, 15(10), e0240533. https://doi.org/10.1371/journal.pone.0240533.

  73. Kim, B. M., Kim, D. H., Park, J. H., Na, H. K., & Surh, Y. J. (2013). Ginsenoside Rg3 Induces Apoptosis of Human Breast Cancer (MDA-MB-231) Cells. Journal of cancer prevention, 18(2), 177–185. https://doi.org/10.15430/jcp.2013.18.2.177.

  74. Song JH, Eum DY, Park SY, Jin YH, Shim JW, Park SJ, Kim MY, Park SJ, Heo K, Choi YJ. Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells. PLoS One. 2020 Oct 22;15(10):e0240533. doi: 10.1371/journal.pone.0240533. PMID: 33091036; PMCID: PMC7580975.

  75. Xia, J., Ma, S., Zhu, X., Chen, C., Zhang, R., Cao, Z., Chen, X., Zhang, L., Zhu, Y., Zhang, S., Li, S., Gu, G., Wei, X., Yu, K., & Wang, J. (2022). Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches. Science advances, 8(6), eabj1262. https://doi.org/10.1126/sciadv.abj1262.

  76. Sun, M. Y., Song, Y. N., Zhang, M., Zhang, C. Y., Zhang, L. J., & Zhang, H. (2019). Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9. Oncology letters, 17(1), 965–973. https://doi.org/10.3892/ol.2018.9701.

  77. Wu, W., Zhou, Q., Zhao, W., Gong, Y., Su, A., Liu, F., Liu, Y., Li, Z., & Zhu, J. (2018). Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton. Journal of medicinal food, 21(9), 849–857. https://doi.org/10.1089/jmf.2017.4144.

  78. Kim, H. S., Lee, E. H., Ko, S. R., Choi, K. J., Park, J. H., & Im, D. S. (2004). Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Archives of pharmacal research, 27(4), 429–435. https://doi.org/10.1007/BF02980085.

  79. Xu, T. M., Cui, M. H., Xin, Y., Gu, L. P., Jiang, X., Su, M. M., Wang, D. D., & Wang, W. J. (2008). Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chinese medical journal, 121(15), 1394–1397.

  80. Available at https://pubs.acs.org/doi/10.1021/acs.jafc.7b02386.

  81. Available at https://onlinelibrary.wiley.com/doi/full/10.1111/cpr.12696.

  82. Park, M. W., Ha, J., & Chung, S. H. (2008). 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK. Biological & pharmaceutical bulletin, 31(4), 748–751. https://doi.org/10.1248/bpb.31.748.

  83. Lee, O. H., Lee, H. H., Kim, J. H., & Lee, B. Y. (2011). Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes. Phytotherapy research : PTR, 25(5), 768–773. https://doi.org/10.1002/ptr.3322.

  84. Kim, K. S., Jung Yang, H., Lee, I. S., Kim, K. H., Park, J., Jeong, H. S., Kim, Y., Seok Ahn, K., Na, Y. C., & Jang, H. J. (2015). The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice. Scientific reports, 5, 18325. https://doi.org/10.1038/srep18325.

  85. Wang, H., Wu, W., Wang, G., Xu, W., Zhang, F., Wu, B., & Tian, Y. (2019). Protective effect of ginsenoside Rg3 on lung injury in diabetic rats. Journal of cellular biochemistry, 120(3), 3323–3330. https://doi.org/10.1002/jcb.27601.

  86. Zhou, T., Sun, L., Yang, S., Lv, Y., Cao, Y., Gang, X., & Wang, G. (2020). 20(S)-Ginsenoside Rg3 Protects Kidney from Diabetic Kidney Disease via Renal Inflammation Depression in Diabetic Rats. Journal of diabetes research, 2020, 7152176. https://doi.org/10.1155/2020/7152176.

  87. Kim, M., Ahn, B. Y., Lee, J. S., Chung, S. S., Lim, S., Park, S. G., Jung, H. S., Lee, H. K., & Park, K. S. (2009). The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes. Biochemical and biophysical research communications, 389(1), 70–73. https://doi.org/10.1016/j.bbrc.2009.08.088.

  88. Saba, E., Kim, S. H., Kim, S. D., Park, S. J., Kwak, D., Oh, J. H., Park, C. K., & Rhee, M. H. (2018). Alleviation of diabetic complications by ginsenoside Rg3-enriched red ginseng extract in western diet-fed LDL-/- mice. Journal of ginseng research, 42(3), 352–355. https://doi.org/10.1016/j.jgr.2017.04.004.

  89. Kim, S. S., Jang, H. J., Oh, M. Y., Eom, D. W., Kang, K. S., Kim, Y. J., Lee, J. H., Ham, J. Y., Choi, S. Y., Wee, Y. M., Kim, Y. H., & Han, D. J. (2014). Ginsenoside Rg3 enhances islet cell function and attenuates apoptosis in mouse islets. Transplantation proceedings, 46(4), 1150–1155. https://doi.org/10.1016/j.transproceed.2013.12.028.

  90. Kim YJ, Park SM, Jung HS, Lee EJ, Kim TK, Kim TN, Kwon MJ, Lee SH, Rhee BD, Kim MK, Park JH. Ginsenoside Rg3 prevents INS-1 cell death from intermittent high glucose stress. Islets. 2016 Apr 18;8(3):57-64. doi: 10.1080/19382014.2016.1161874. PMID: 27246809; PMCID: PMC4987017.

  91. Kang, K. S., Yamabe, N., Kim, H. Y., Park, J. H., & Yokozawa, T. (2008). Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats. European journal of pharmacology, 591(1-3), 266–272. https://doi.org/10.1016/j.ejphar.2008.06.077.

  92. Lee, J. B., Yoon, S. J., Lee, S. H., Lee, M. S., Jung, H., Kim, T. D., Yoon, S. R., Choi, I., Kim, I. S., Chung, S. W., Lee, H. G., Min, J. K., & Park, Y. J. (2017). Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ. The Journal of endocrinology, 235(3), 223–235. https://doi.org/10.1530/JOE-17-0233.

  93. Guo, M., Guo, G., Xiao, J., Sheng, X., Zhang, X., Tie, Y., Cheng, Y. K., & Ji, X. (2018). Ginsenoside Rg3 stereoisomers differentially inhibit vascular smooth muscle cell proliferation and migration in diabetic atherosclerosis. Journal of cellular and molecular medicine, 22(6), 3202–3214. https://doi.org/10.1111/jcmm.13601.

  94. Ni, J., Liu, Z., Jiang, M., Li, L., Deng, J., Wang, X., Su, J., Zhu, Y., He, F., Mao, J., Gao, X., & Fan, G. (2022). Ginsenoside Rg3 ameliorates myocardial glucose metabolism and insulin resistance via activating the AMPK signaling pathway. Journal of ginseng research, 46(2), 235–247. https://doi.org/10.1016/j.jgr.2021.06.001.

  95. Liu, T., Peng, Y. F., Jia, C., Yang, B. H., Tao, X., Li, J., & Fang, X. (2015). Ginsenoside Rg3 improves erectile function in streptozotocin-induced diabetic rats. The journal of sexual medicine, 12(3), 611–620. https://doi.org/10.1111/jsm.12779.

Other Peptides

Valproic Acid

Elampretide (SS-31)

Nicotinamide Adenine Dinucleotide (NAD+)

Sermorelin

Melanotan 2

Success Stories

men testimonial before after

At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions I’ve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old Movie Director (“The Notebook”, “John Q”, “Alpha Dog”), Actor and Writer

See All Men’s Testimonials

Call 800-277-4041 for a Free Consultation

What to expect during your consultation:
  • Usually takes 15-30 minutes
  • Completely confidential
  • No obligation to purchase anything
  • We will discuss your symptoms along with your health and fitness goals
  • Free post-consult access for any additional questions you may have

About

Genemedics® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.

Quick Links

Our Services

 Our Locations

genemedics logo

280 North Old Woodward Ave. Suite 210 Birmingham MI 48009,USA

800-277-4041

info@genemedics.com

© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.

Back to Top
-

Free Consultation

STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!

Call 800-277-4041 for a Free Consultation

What to expect during your consultation:

  • Usually takes 15-30 minutes
  • Completely confidential
  • No obligation to purchase anything
  • We will discuss your symptoms along with your health and fitness goals
  • Free post-consult access for any additional questions you may have
Captch Background